SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001469709-16-000755
Filing Date
2016-04-05
Accepted
2016-04-04 17:40:07
Documents
55
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 ENDV 10-K 12/31/15 endv10k_123115apg.htm 10-K 587188
2 GRAPHIC endv10k_123115apg001.jpg GRAPHIC 41005
3 EXHIBIT 31.1 ex31_1apg.htm EX-31.1 7489
4 EXHIBIT 32.1 ex32_1apg.htm EX-32.1 3174
5 EXHIBIT 3.7 ex3_7apg.htm EX-3.7 1154
6 GRAPHIC ex3_7apg002.gif GRAPHIC 804240
7 GRAPHIC ex3_7apg004.gif GRAPHIC 720818
8 EXHIBIT 4.1 ex4_1apg.htm EX-4.1 828
9 GRAPHIC ex4_1apg002.gif GRAPHIC 1366087
  Complete submission text file 0001469709-16-000755.txt   6638285

Data Files

Seq Description Document Type Size
10 XBRL INSTANCE FILE endv-20151231.xml EX-101.INS 390828
11 XBRL SCHEMA FILE endv-20151231.xsd EX-101.SCH 39315
12 XBRL CALCULATION FILE endv-20151231_cal.xml EX-101.CAL 39428
13 XBRL DEFINITION FILE endv-20151231_def.xml EX-101.DEF 49419
14 XBRL LABEL FILE endv-20151231_lab.xml EX-101.LAB 203194
15 XBRL PRESENTATION FILE endv-20151231_pre.xml EX-101.PRE 164354
Mailing Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367
Business Address 6320 CANOGA AVENUE 15TH FLOOR WOODLAND HILLS CA 91367 (800) 489-4774
ENDONOVO THERAPEUTICS, INC. (Filer) CIK: 0001528172 (see all company filings)

IRS No.: 452552528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55453 | Film No.: 161552099
SIC: 2834 Pharmaceutical Preparations